Abstract
In recent years there has been a considerable increase in studies of bactericidal peptides produced by Grampositive bacteria, with particular emphasis upon their potential application as food preservatives. A number of these peptides contain lanthionine and other post-translationally modified amino acid residues. The lanthionine-containing molecules (lantibiotic) appear to have evolved in two quite different lineages, type A and type B. This mini-review introduces the reader to several of the more recently described type A lantibiotics for which relatively detailed biochemical and/or genetic data has already been gathered. A wider diversity of compounds of type A lantibiotics has been described in the recent years. Novel features of some of the more recently described type A lantibiotics to be reported in this review include: a) New modifications such as D-Ala and 2-hydroxypropionyl residues, both derived from serine. b) Different types of pre-lantibiotic leader sequences. c) The apparent requirement for different numbers and types of genes for synthesis of some active type A lantibiotics. d) Cytolysin functions as both a hemolysin and a bacteriocin. e) One of the newly-described lantibiotics (lactocin S) does not have any net charge at neutral pH another (carnocin UI49) is the largest of the lantibiotics discovered and the killing action of another (cytolysin) has been shown to be depend on the interaction of two peptides.
Similar content being viewed by others
References
Allgaier H, Jung G, Werner RG, Schneider U & Zähner H (1986) Epidermin: sequencing a heterdet tetracyclic 21-peptide amide antibiotic. Eur. J. Biochem. 160: 9–22
Brock TD & Davie JM (1963) Probable identity of a group D hemolysin with a bacteriocin. J. Bacteriol. 86: 708–712
Dempster RP & Tagg JR (1982) The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius. Arch. Oral Biol. 27: 151–157
Danny FG & Clewell DB (1975) Transmissible toxin (hemolysin) plasmid in Streptococcus faecalis and its mobilization to a non-infectious drug resistant plasmid. J. Bacteriol. 124: 784–790
Gillmore MS, Segarra RA, Booth MC, Bogie CP, Hall LR & Clewell DB (1994) Genetic structure of the Enterococcus faecalis plasmid pAS1-encoded cytolytic toxin system and its relationship to lantibiotic determinants. J. Bacteriol. 176: 7335–7344
Gratia A. (1925) Sur un remarquable exemple d'antagonisme entre deux souches de colibacille. C.R. Séances Soc. Biol. Fil. 93: 1040–1041
Gross E. & Morell JL (1971) The structure of nisin. J. Am. Chem. Soc. 93: 4634–4635
Gross E., Klitz HH & Nebelin E (1973) Die Struktur des Subtilins. Hoppe-Seyler's Z. Physiol. Chem. 354: 810–812
Havarstein LS, Holo H & Nes IF (1994) The leader peptide of colicin V shares consensus sequences with leader peptides that are common among peptide bacteriocins produced by Gram-positive bacteria. Microbiology 140: 2383–2389
Hryniewicz W & Tagg JR (1976) Bacteriocin production by group A streptococcal L-forms. Antimicrobial Agents Chemother. 10: 912–914
Hynes WL, Friend VL & Ferretti JJ (1994) Duplication of the lantibiotic structural gene in M-type 49 group A streptococcus strains producing streptococcin A-M49. Appl. Envir. Microbiol. 60: 4207–4209
Hynes WL, Ferretti JJ & Tagg JR (1993) Cloning of the gene encoding streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence. Appl. Environ. Microbiol. 59: 1969–1971
Jack RW, Carne A, Metzger J, Stefanovitc S, Sahl H-G, Jung G & Tagg JR (1994) Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22. Eur. J. Biochem. 220: 455–462
Jack RW, Benz R, Tagg JR & Sahl H-G (1994) The mode of action of SA-FF22 a lantibiotic produced by Streptococcus pyogenes strain FF22. Eur. J. Biochem. 219: 699–705
Jack RW & Tagg JR (1992) Factors affecting the production of the group A streptococcus bacteriocin SA-FF22. J. Med. Microbiol. 36: 132–138
Jack RW & Tagg JR (1991) Isolation and partial structure of streptococcin A-FF22. In: Jung G & Sahl H-G (Eds) Nisin and Novel Lantibiotics (pp. 171–179) Escom Publishers, Leiden, The Netherlands
Jacob A, Douglas GJ & Hobbs SJ (1975) Self-transferable plasmids determining the hemolysin and bacteriocin of Streptococcus faecalis var. zymogenes. J. Bacteriol. 121: 863–872
Jacob F, Lwoff A, Siminovitch A & Wollman E (1953) Définition de qualques termes relatifs à la lysogénie. Ann. Inst. Pasteur (Paris) 84: 222–224
Jung G (1991) Lantibiotics — ribosomally synthesized biologically active polypeptides containing sulfide bridges and α,β-didehydroamino acids. Angew. Chem. Int. Ed. Engl. 30: 1051–1192
Jung G & Sahl H-G (1991) Nisin and novel lantibiotics. Escom Publishers, Leiden, The Netherlands
Kellner R, Jung G, Hörner T, Zähner H, Schnell N, Entian K-D & Götz F (1988) Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem. 177: 53–59
Kellner R, Jung G, Josten G, Kaletta C, Entian K-D & Sahl H-G (1989) Pep5: structure elucidation of a large lantibiotic. Angew. Chem. Int. Ed. Engl. 28: 616–619
Kellner R, Jung G & Sahl H-G (1991) In: Jung G & Sahl H-G (Eds) Nisin and Novel Lantibiotics (pp 141–158) Escom Publishers, Leiden, The Netherlands
Kuipers OP, Beerthuyzen MM, Siezen RJ & deVoss WM (1993) Characterization of the nisin gene cluster nisABCIPR of Lactococcus lactis; requirement of expression of nisA and nisI genes for development of immunity. Eur. J. Biochem. 216: 281–291
Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 12: 39–86
Novak J, Caufield PW & Miller EJ (1994) Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans. J. Bacteriol. 176: 4316–4320
Mørtvedt C & Nes IF (1990) Plasmid-associated bacteriocin production by a Lactobacillus sake strain. J. Gen. Microbiol. 136: 1601–1607
Mørtvedt C, Nissen-Meyer J, Sletten K & Nes IF (1991) Purification and amino acid sequence of lactocin S, a bacteriocin produced by Lactobacillus sake L45. Appl. Environ. Microbiol. 57: 1829–1834
Mørtvedt-Abildgaard CI, Nissen-Meyer J, Jelle B, Grenov B, Skaugen M & Nes IF (1995) Lactocin S, a lantibiotic from Lactobacillus sake L45: Studies of its production and pH dependent bacteriocidal activity. Appl. Environ. Microbiol. 61: 175–179
Mulders JWM, Boerrigter IJ, Rollema HS, Siezen RJ & deVos WM (1991) Identification and characterization of the lantibiotic nisin Z, a natural nisin variant. Eur. J. Biochem. 201: 581–584
Nissen-Meyer J, Holo H, Havarstein LV, Sletten K & Nes IF (1992) A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides. J. Bacteriol. 174: 5686–5692
Piard J-C, Kuipers OP, Rollema HS, Desmazeaud MJ & deVos WM (1993a) Structure, organization and expression of the lct gene for lacticin 481, a novel lantibiotic produced by Lactococcus lactis. J. Biol. Chem. 268: 16361–16368
Piard J-C, Muriana PM, Desmazeaud MJ & Klaenhammer TR (1992) Purification and partial characterization of lacticin 481, a lanthionine-containing bacteriocin produced by Lactococcus lactis subsp. lactis CNRZ 481. Appl. Environ. Microbiol. 58: 279–284
Rince A, Dufour A, Pogam SLE, Thuault D, Bourgois CM & LePennec JP (1994) Cloning, expression, and nucleotide sequence of genes involved in production of lactococcin DR, a bacteriocin from Lactococcus lactis subsp. lactis. Appl. Envir. Microbiol. 60: 1652–1657
Ross KF, Ronson CW & Tagg JR (1993) Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl. Environ. Microbiol. 59: 2014–2021
Schnell N, Entian KD, Schneíder U, Gotz F, Zèhner H, Kelllner R & Jung G (1988) Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulfide-rings. Nature (London) 333: 276–278
Scott JC, Sahl H-G, Carne A & TaggJr (1992) Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphyloccus aureus isolate. FEMS Microbiol. Letts. 93: 97–102
Skaugen M, Nissen-Meyer J, Jung G, Stevanovic S, Sletten K, Mørtvedt Abildgaard C-I & Nes IF (1994) Introduction of D-Ala by modification of L-Ser. J. Biol. Chem. 269: 27183–27185
Skaugen M (1994) Lactocin S: structure determination and genetic analysis. Doctoral thesis. Agricultural University of Norway, Ås, Norway
Simpson WJ & Tagg JR (1986) Relationship between bacteriocinogenicity and plasmid content in streptococci of Lancefield groups B, C, E and G. Proc. Univ. Otago Med. Sch. 64: 25–26
Stoffels G, Nes IF & Gudmundsdottir A (1992a) Isolation and properties of a bacteriocin-producing Carnobacteriumpiscicola strain isolated from fish. J. Appl. Bacteriol. 73: 309–316
Stoffels G, Nissen-Meyer J, Gudmundsdottir A, Sletten K, Holo H & Nes IF (1992b) Purification and characterization of a new bacteriocin from a Carnobacterium ssp. Appl. Environ. Microbiol. 58: 1417–1422
Stoffels G, Gudmundsdottir A & Abee T (1994) Membraneassociated proteins encoded by the nisin gene cluster may function as a receptor for the lantibiotic carnocin UI49. Microbiology 140: 1443–1450
Tagg JR, Read RSD & McGiven AR (1971) Bacteriocin production by group A streptococci. Pathology 3: 277–278
Tagg JR, Dajani AS, Wannamaker LW & Gray ED (1973a) Group A streptococcal bacteriocin. Production, purification and mode of action. J. Exp. Med. 138: 1168–1183
Tagg JR, Read RSD & McGiven AR (1973b) Bacteriocin of a group A streptococcus: partial purification and properties. Antimicrob. Agents Chemother. 4: 214–221
Tagg JR, Skjold S & Wannamaker LW (1976) Transduction of bacteriocin determinants in group A streptococci. J. Exp. Med. 143: 1540–1544
Tagg JR & Wannamaker LW (1976) Genetic basis of streptococcin A-FF22 production. Antimicrobial. Agents Chemother. 10: 299–306
Tagg JR & Wannamaker LW (1978) Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus. Antimicrobial. Agents hemother. 14: 31–39
Tagg JR & Bannister LV (1979) Fingerprinting β-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J. Med. Microbiol. 12: 397–411
Tagg JR, Pybus V, Phillips LV & Fiddes TM (1983) Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius. Arch. Oral Biol. 10: 911–915
Tagg JR & Skjold SA (1984) A bacteriocin produced by certain M-type 49 Streptococcus pyogenes strains when incubated anaerobically. J. Hyg. 92: 339–344
Tagg JR (1985) Bacteriocin production by rheumatoginic and nephritogenic streptococci. Recent advances in streptococci and streptococcal diseases. Surrey, Reedbooks Ltd.
Tompkins GR & Tagg JR (1989) The ecology of bacteriocin-producing strains of Streptococcus salivarius. Microbial Ecology in Health and Disease 2: 19–28
Van deKamp M, Horstink LM, van denHoven IW, Konings RNH, Hilbers CW, Frey A, Sahl H-G, Metzger JW & van deVen FJM (1995) Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Eur. J. Biochem. 227: 757–771
Van de Kamp M, van den Hooven HW, Konings RNH, Hilbers CW, van de Ven FJM, Bierbaum G, Sahl H-G, Kuipers OP, Siezen RJ, deVos WM (1995) Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Eur. J. Biochem. 227: in press
Van deKamp M, Horstink L-M, Stevens A, van denHooven HW, Mronga S, Konings RNH, Hilbers CW, van deVen FJM, Bierbaum G, Frey A, Sahl H-G, Metzger JW, Jung G, Kuipers OP, Siezen RJ, deVos WM (1994) Epilancin K7, a novel lantibiotic from Staph. epidermidis. Primary structure, gene sequence, and studies with micelles. Abstract. At the 2nd. International Workshop on Lantibiotics. November 20–23, 1994. Papendal, Arnhem, The Netherlands
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nes, I.F., Tagg, J.R. Novel lantibiotics and their pre-peptides. Antonie van Leeuwenhoek 69, 89–97 (1996). https://doi.org/10.1007/BF00399414
Issue Date:
DOI: https://doi.org/10.1007/BF00399414